Early trial tests new drug combo for Tough-to-Treat leukemia
Disease control
Terminated
This early-stage study tested a new drug, CWP232291, combined with an existing chemotherapy (cytarabine) for adults with acute myeloid leukemia (AML) that had returned or stopped responding to prior treatments. The main goals were to find a safe dose and see if the combination sh…
Phase: PHASE1, PHASE2 • Sponsor: JW Pharmaceutical • Aim: Disease control
Last updated Feb 17, 2026 14:37 UTC